Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GJB2 | P29033 | 4/20 | 0.53 |
| ▸ | TACR2 | P21452 | 3/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | NT5E | P21589 | 1/20 | 0.47 |
| ▸ | GJA1 | P17302 | 2/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.43 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.43 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.43 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.43 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.42 |
| ▸ | CDC25B | P30305 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4007928 | 1.00 | GJB2 (0.53) | GJB2TACR2HTR1ANT5EGJA1 | |
| SCHEMBL21843054 | 1.00 | GJB2 (0.53) | GJB2TACR2HTR1ANT5EGJA1 | |
| SCHEMBL7150778 | 1.00 | GJB2 (0.53) | GJB2TACR2HTR1ANT5EGJA1 | |
| SCHEMBL7150775 | 1.00 | GJB2 (0.53) | GJB2TACR2HTR1ANT5EGJA1 | |
| SCHEMBL13797895 | 1.00 | GJB2 (0.53) | GJB2TACR2HTR1ANT5EGJA1 | |
| SCHEMBL5473075 | 0.93 | GJB2 (0.52) | GJB2TACR2HTR1ANT5EGJA1 | |
| SCHEMBL9114888 | 0.93 | GJB2 (0.47) | GJB2TACR2HTR1ANT5EBCHE | |
| SCHEMBL13430417 | 0.93 | GJB2 (0.52) | GJB2TACR2HTR1ANT5EGJA1 | |
| SCHEMBL9114883 | 0.93 | GJB2 (0.47) | GJB2TACR2HTR1ANT5EBCHE | |
| SCHEMBL13430414 | 0.93 | GJB2 (0.52) | GJB2TACR2HTR1ANT5EGJA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7541456-B2 | Enolization; dimerization; trimerization; for synthesis of sugar molecules | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2009-06-02 | — | — | US | disclosed |
| EP-1501777-A4 | DIRECT, ENANTIOSELECTIVE ALDOL COUPLING OF ALDEHYDES USING CHIRAL ORGANIC CATALYSTS | CALIFORNIA INST OF TECHN (US) | 2007-03-28 | — | — | EP | disclosed |
| US-20050197498-A1 | Enolization; dimerization; trimerization; for synthesis of sugar molecules | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-09-08 | — | — | US | disclosed |
| US-6900357-B2 | Comprises (2S,5S)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one as catalyst; for synthesis of (2S,3S)-3-hydroxy-2-methylpentanal | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-05-31 | — | — | US | disclosed |
| EP-1501777-A1 | DIRECT, ENANTIOSELECTIVE ALDOL COUPLING OF ALDEHYDES USING CHIRAL ORGANIC CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-02-02 | — | — | EP | disclosed |
| US-20040024221-A1 | Comprises (2S,5S)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one as catalyst; for synthesis of (2S,3S)-3-hydroxy-2-methylpentanal | MACMILLAN DAVID W C (US) | 2004-02-05 | — | — | US | disclosed |
| WO-2003089396-A1 | DIRECT, ENANTIOSELECTIVE ALDOL COUPLING OF ALDEHYDES USING CHIRAL ORGANIC CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2003-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040024221-A1 | Comprises (2S,5S)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one as catalyst; for synthesis of (2S,3S)-3-hydroxy-2-methylpentanal | ADH1C, ADH5, ALDH3A1 | GJB2 2098/4885TACR2 3744/4885HTR1A 1947/4885 |
| US-20050197498-A1 | Enolization; dimerization; trimerization; for synthesis of sugar molecules | DERA, ALDOA, TALDO1 | GJB2 1333/4885TACR2 2297/4885HTR1A 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.